Moderator:
Sylvia Ehle, MHA
Director, Professional Education
Panel:
Elena Fisher, DNP, FNP-C
Victoria Barden, PA-C
This program made possible in part by:
Building Blocks to Better IBD Veteran Patient Care: The APP Perspective
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Overview
Recommended
Details
Presenters
Overview
Moderator:
Sylvia Ehle, MHA
Director, Professional EducationPanel:
Elena Fisher, DNP, FNP-C
Victoria Barden, PA-CThis program made possible in part by:
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
1.00 credits
<p>Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring</p>
CME/CE
Updates From the 7th World Symposium Task Force
1.00 credits
<p><span data-contrast="auto" xml:lang="EN-US">Updates From the 7th World Symposium Task Force</span><span data-ccp-props='{"201341983":0,"335559738":210,"335559739":210,"335559740":240}'> </span></p>
CME/CE
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
0.50 credits
<p>New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure</p>
MinuteCE®
HF Management for Patients with Comorbid Conditions
0.75 credits
<p>HF Management for Patients with Comorbid Conditions</p>
MinuteCE®
CETP inhibition: Lessons from two decades of clinical trials
0.50 credits
<p><span data-contrast="none" style="list-style-type: disc;" xml:lang="EN-US">CETP inhibition: Lessons from two decades of clinical trials</span></p>
CME/CE
AHA 2024 and Acoramidis: Impact on the Future of ATTR-CM Patient Care
<p>AHA 2024 and Acoramidis: Impact on the Future of ATTR-CM Patient Care</p>
NeuroFrontiers
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
<p>Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data</p>
Clinician's Roundtable
Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025
<p>Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?